Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MR-flow to Validate Hemodynamic Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome: Can MRI and Echocardiography Predict the Pharmacological Response and Longterm Effect of Terlipressin?

NCT03483272 is registered in ClinicalTrials.gov with Hvidovre University Hospital as lead sponsor.

NCT NCT03483272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03483272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MR-flow to Validate Hemodynamic Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome: Can MRI and Echocardiography Predict the Pharmacological Response and Longterm Effect of Terlipressin?
Lead sponsor
Hvidovre University Hospital
Phase
Observational
Overall status
Completed
Start date
January 8, 2018
Completion date
April 21, 2021
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cirrhosis, cirrhosis cardiac, hepato-renal syndrome, liver cirrhoses, liver diseases, portal hypertension